In the burgeoning field of pharmacogenetics, adhering to expert-developed guidelines is increasingly important, a Stanford Medicine physician emphasizes.
Stanford Medicine researchers found that, based on genetic makeup, 99.5% of people are likely to have an atypical response to at least one drug.
As part of the series,Breaking down diabetes, physician Randall Stafford provides a straightforward guide to medications that can treat Type 2 diabetes.
Metformin is physician-researcher Randall Stafford's go-to drug for diabetes. He explains why in this installment in the series, Breaking down diabetes.
Researchers have developed a sensor system on a smartwatch that uses sweat to determine the level of acetaminophen in the body.
A Stanford oncologist discusses how to improve cancer diagnosis and treatment, including using predictive modeling, liquid biopsies and immunotherapy.
Lasers, heat maps, fluorescence and real-time imaging help guide surgeons who are developing new ways to enhance precision brain surgery.
Inspired by personal experience, Stanford Medicine's Megan Mahoney devised a primary care pilot to center around patients and their goals.
In initial feedback, patients and providers favored the precision health approach to primary care demonstrated in Stanford Medicine's Humanwide pilot.
On LinkedIn, Dean Lloyd Minor outlines how precision health that takes into account environmental factors can improve well-being throughout a population.
After receiving a donated kidney from his father, a patient strives to stay healthy by monitoring key data with a Stanford Medicine Humanwide team.
Data from an at-home device through the Humanwide project help a patient and his primary care team discover hypertension that wasn't detected at the clinic.
A patient worried that cancer may run in her family finds answers through genetic testing offering by Stanford Medicine's Humanwide project.
Stephen Montgomery, a Stanford associate professor of pathology and of genetics, describes how he uses RNA to understand health.
Scientists monitored 106 individuals (some of whom have prediabetes) to see how the condition, and infections, impact immune-and-microbiome-related health.
Six episodes explain the Stanford Medicine pilot project, which used patient data to create personalized health plans addressing concerns and risks.